Cisplatin versus Cetuximab With Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: an Analysis of Veteran’s Health Data

অনুরূপ উপাদানগুলি

• Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
  অনুযায়ী: Bauml, Joshua M, অন্যান্য
  প্রকাশিত: (2018)
• Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
  অনুযায়ী: Sun, Lova, অন্যান্য
  প্রকাশিত: (2021)
• Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018
  অনুযায়ী: Parikh, Ravi B., অন্যান্য
  প্রকাশিত: (2020)
• How Much Is Life Worth: Cetuximab, Non–Small Cell Lung Cancer, and the $440 Billion Question
  অনুযায়ী: Fojo, Tito, অন্যান্য
  প্রকাশিত: (2009)
• Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
  অনুযায়ী: Argiris, Athanassios, অন্যান্য
  প্রকাশিত: (2010)